Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AUTOREST: Pramipexole in Restless Legs Syndrome
NCT02025608Phase 4Completed
- Start
- Dec 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of pramipexole in restless legs syndrome (RLS). Primary endpoint: Change in heart rate activations during sleep at 4 weeks. Started Dec 2013; status: completed.
02
Drugs
pramipexole
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on NCT02025608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02025608.